Wolfgang Miesbach: Grateful to the Organisers and Pfizer for this Invaluable Opportunity
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
“Honoured to have presented virtually at the 2025 Hemophilia Summit in Shenzhen, China on Advancing Shared Decision Making in the Era of Novel Haemophilia Therapies!
The presentation explored how patient values, life stages, and individual priorities should shape treatment goals.
It’s not just about preventing bleeds anymore—it’s about optimising quality of life, preserving joint health, and enabling meaningful participation in everyday activities.
Key themes covered:
- Understanding diverse treatment pathways and their trade-offs
- Recognising life-stage specific needs (childhood, adolescence, adulthood, aging)
- Practical frameworks for eliciting patient priorities and concerns
- Real case studies demonstrating SDM in action—from teenagers transitioning to university to elderly patients with chronic arthropathy
- Transition checklists and decision documentation tools
Delighted to have engaged with colleagues across China and the broader Asian hemophilia community—sharing evidence-based practice whilst learning from clinical experiences and patient perspectives in Asia.
Grateful to the organisers and Pfizer for this invaluable opportunity to contribute to advancing patient-centred care globally.”
Read the full article here.
Follow the latest in Hemostasis Today.
-
Jun 1, 2026, 15:20Venugopalan Unni: Guidelines for the Evaluation and Management of Acute Pulmonary Embolism in Adults
-
Jun 1, 2026, 15:10Smitirupa Mishra: Standardizing RBC Morphology Reporting – Why ICSH Guidelines Matter?
-
Jun 1, 2026, 14:54Davide Massimi: A Bloodless Approach to Third Space Endoscopy
-
Jun 1, 2026, 14:27Afshan Sumera: Plasma Proteomics Reveals Complement And Coagulation Disruption In Transfusion-Dependent Thalassemia
-
Jun 1, 2026, 13:44Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
-
Jun 1, 2026, 13:39Abdul Mannan: The Moral Injury of Practising Haemato-Oncology in a Resource-Limited Setting
-
Jun 1, 2026, 13:34Filza Aslam: What Does a Patient Journey Partner Actually Do in Bleeding Disorders?
-
Jun 1, 2026, 13:33Darine Ghanem: Advancing Health Equity in Care at the LATAM Meeting
-
Jun 1, 2026, 13:23Skye Collado: Miller-Keystone Blood Center Expands Community Impact Through the Addition of New Bloodmobiles